Literature DB >> 8208618

Effect of abasic linker substitution on triplex formation, Sp1 binding, and specificity in an oligonucleotide targeted to the human Ha-ras promoter.

C Mayfield1, D Miller.   

Abstract

A region of the human Ha-ras promoter (-8 to -28) which contains two of the three Sp1 binding sites essential for transcriptional activity forms a sequence specific oligonucleotide-directed pur*pur:pyr triple helix. The relative binding of oligonucleotides containing different substitutions, including an abasic propanediol linker, over three potentially destabilizing C:G interruptions in the otherwise poly G:poly C target was examined. DNase I footprint titrations reveal that substitution of the positively charged abasic propanediol linker results in approximately ten fold greater binding than cytosine substitution which in turn provides greater sequence specific binding than substitution of a guanine in the third strand oligonucleotide over the C:G interruptions. Protein binding assays demonstrate that triplex formation by the linker substituted oligomer (HR21Xap) is less effective in inhibiting Sp1 binding than the cytosine substituted oligomer (HR21ap) both to the target sequence as well as an upstream sequence. As an indication of the effect of linker substitution and targeting consensus Sp1 sites on triplex specificity, the relative ability of the Ha-ras promoter targeted oligonucleotides to interact with non-target Sp1 sequences within the Ha-ras promoter as well as in the DHFR promoter and HIV-1 LTR was also investigated. At concentrations which afford complete DNase I protection of the target sequence, HR21ap does not bind to the non-target sequences while HR21Xap interacts weakly only at a distal site in the DHFR promoter. Also, HR21ap as well as HR21Xap are specific in their inhibition of Sp1 binding. These results suggest that the propanediol linker is able to skip over interruptions in a target sequence thereby stabilizing triplex but, slightly compromises sequence specificity and the ability to inhibit Sp1 binding to the Ha-ras promoter.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8208618      PMCID: PMC308093          DOI: 10.1093/nar/22.10.1909

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  27 in total

1.  Second structural motif for recognition of DNA by oligonucleotide-directed triple-helix formation.

Authors:  P A Beal; P B Dervan
Journal:  Science       Date:  1991-03-15       Impact factor: 47.728

2.  DNA triplex formation of oligonucleotide analogues consisting of linker groups and octamer segments that have opposite sugar-phosphate backbone polarities.

Authors:  A Ono; C N Chen; L S Kan
Journal:  Biochemistry       Date:  1991-10-15       Impact factor: 3.162

3.  Oligonucleotide inhibition of IL2R alpha mRNA transcription by promoter region collinear triplex formation in lymphocytes.

Authors:  F M Orson; D W Thomas; W M McShan; D J Kessler; M E Hogan
Journal:  Nucleic Acids Res       Date:  1991-06-25       Impact factor: 16.971

Review 4.  The chemistry and biology of unusual DNA structures adopted by oligopurine.oligopyrimidine sequences.

Authors:  R D Wells; D A Collier; J C Hanvey; M Shimizu; F Wohlrab
Journal:  FASEB J       Date:  1988-11       Impact factor: 5.191

5.  Inhibition of DNA binding proteins by oligonucleotide-directed triple helix formation.

Authors:  L J Maher; B Wold; P B Dervan
Journal:  Science       Date:  1989-08-18       Impact factor: 47.728

6.  Effects of an abasic site on triple helix formation characterized by affinity cleaving.

Authors:  D A Horne; P B Dervan
Journal:  Nucleic Acids Res       Date:  1991-09-25       Impact factor: 16.971

7.  Evidence that a triplex-forming oligodeoxyribonucleotide binds to the c-myc promoter in HeLa cells, thereby reducing c-myc mRNA levels.

Authors:  E H Postel; S J Flint; D J Kessler; M E Hogan
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

8.  Binding of triple helix forming oligonucleotides to sites in gene promoters.

Authors:  R H Durland; D J Kessler; S Gunnell; M Duvic; B M Pettitt; M E Hogan
Journal:  Biochemistry       Date:  1991-09-24       Impact factor: 3.162

9.  Sequence specificity in triple-helix formation: experimental and theoretical studies of the effect of mismatches on triplex stability.

Authors:  J L Mergny; J S Sun; M Rougée; T Montenay-Garestier; F Barcelo; J Chomilier; C Hélène
Journal:  Biochemistry       Date:  1991-10-08       Impact factor: 3.162

10.  Site-specific inhibition of EcoRI restriction/modification enzymes by a DNA triple helix.

Authors:  J C Hanvey; M Shimizu; R D Wells
Journal:  Nucleic Acids Res       Date:  1990-01-11       Impact factor: 16.971

View more
  5 in total

Review 1.  Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects.

Authors:  R A Stull; F C Szoka
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

2.  Synthesis and monitored selection of nucleotide surrogates for binding T:A base pairs in homopurine-homopyrimidine DNA triple helices.

Authors:  A A Mokhir; W H Connors; C Richert
Journal:  Nucleic Acids Res       Date:  2001-09-01       Impact factor: 16.971

3.  Effect of competing self-structure on triplex formation with purine-rich oligodeoxynucleotides containing GA repeats.

Authors:  S B Noonberg; J C François; T Garestier; C Hélène
Journal:  Nucleic Acids Res       Date:  1995-06-11       Impact factor: 16.971

4.  Single strand targeted triplex formation: targeting purine-pyrimidine mixed sequences using abasic linkers.

Authors:  E R Kandimalla; A N Manning; G Venkataraman; V Sasisekharan; S Agrawal
Journal:  Nucleic Acids Res       Date:  1995-11-11       Impact factor: 16.971

5.  Suppression of c-myc oncogene expression by a polyamine-complexed triplex forming oligonucleotide in MCF-7 breast cancer cells.

Authors:  T J Thomas; C A Faaland; M A Gallo; T Thomas
Journal:  Nucleic Acids Res       Date:  1995-09-11       Impact factor: 16.971

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.